Generation of donor-specific regulatory t-cell function in kidney transplant patients

Transplantation

Volumn 87, Issue 3, 2009, Pages 376-383

  Hendrikx, Thijs K ^a   Van Gurp, Evelien A F J ^a   Sewgobind, Varsha D K D ^a   Mol, Wendy M ^a   Schoordijk, Wenda ^a   Klepper, Masriska ^a   Velthuis, Jurjen H L ^a   Geel, Annemarie ^a   Ijzermans, Jan N M ^a   Weimar, Willem ^a   Baan, Carla C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinical kidney transplantation; Donor specific regulatory T cells; Immunosuppressive drugs

Indexed keywords

MEPREDNISONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN; METHYLPREDNISOLONE;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL SPECIFICITY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOREGULATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; AGED; CHRONIC KIDNEY FAILURE; DONOR; IMMUNOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; STATISTICS;

ADULT; AGED; ANTIGENS, CD; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS;

EID: 61849159327     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181901b69     Document Type: Article

References (43)

1. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145.
2. Strober S, Benike C, Krishnaswamy S, et al. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity. Transplantation 2000; 69: 1549.
3. Roussey-Kesler G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006; 6: 736.
4. Salama AD, Najafian N, Clarkson MR, et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643.
5. Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118.
6. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345.
7. Martinez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309.
8. Long E, Wood KJ. Understanding FOXP3: Progress towards achieving transplantation tolerance. Transplantation 2007; 84: 459.
9. +T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
10. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448.
11. bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosup-pressed kidney allograft patients. Am J Transplant 2006; 6: 2955.
12. Bestard O, Cruzado JM, Mestre M, et al. Achieving donor-specific hy-poresponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007; 179: 4901.
13. Akl A, Jones ND, Rogers N, et al. An investigation to assess the potential of CD25(high)CD4( + ) T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int 2008; 21: 65.
14. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
15. + regulatory T cells: Does in vitro evidence translate to the clinical setting? Transplantation 2008; 85: 783.
16. + T cell suppressor function. J Immunol 2004; 172: 6519.
17. Baan CC, van der Mast BJ, Klepper M, et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005; 80: 110.
18. + Treg cells fit. Nat Immunol 2005; 6: 1071.
19. + regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005; 6: 1152.
20. E van Gurp. Renal function following kidney transplantation is equally good regardless of whether tacrolimus is combined with sirolimus or mycophenolate mofetil [abstract]. Transpl Int 2007; 20: 25.
21. + T reg cells. J Exp Med 2006; 203: 1701.
22. Rodriguez DS, Jankowska-Gan E, Haynes LD, et al. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 2004; 4: 537.
23. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 12: 277.
24. + T cells. Bone Marrow Transplant 2007; 39: 537.
25. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007; 357: 1316.
26. Lohr J, Knoechel B, Abbas AK. Regulatory T cells in the periphery. Immunol Rev 2006; 212: 149.
27. + regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol 2007; 19: 785.
28. + regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol 2003; 171: 3435.
29. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006; 108: 1571.
30. + regulatory T cells in vivo. J Exp Med 2003; 198: 249.
31. Brouard S, Dupont A, Giral M, et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005; 5: 330.
32. Gavin MA, Clarke SR, Negrou E, et al. Homeostasis and anergy of CD4( + )CD25( + ) suppressor T cells in vivo. Nat Immunol 2002; 3:33.
33. + regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 2003; 14: 1652.
34. + regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108: 390.
35. + regulatory T cells. Blood 2006; 107: 1018.
36. + cells in vitro. Am J Transplant 2005; 5: 454.
37. Gao W, Lu Y, El Essawy B, et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T Cells. Am J Transplant 2007; 7: 1722.
38. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
39. Dijke IE, Velthuis JH, Caliskan K, et al. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation 2007; 83: 1477.
40. + cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914.
41. Valmori D, Merlo A, Souleimanian NE, et al. A peripheral circulating compartment of natural naive CD4Tregs.J Clin Invest 2005; 115:1953.
42. Menning A, Hopken UE, Siegmund K, et al. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 2007; 37: 1575.
43. +CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260.